We interrogated the TCGA provisional dataset for association of gene expression alterations in the IGF signalling components analysed above (IGF-1R, IFG-2R, IGFBP4, IRS-1, IRS-2) with survival in breast cancer (Fig. 7). This evidence concerns the gene IRS1 and breast carcinoma.